Title:
BIARYL COMPOUND CAPABLE OF SERVING AS RORγ MODULATOR
Document Type and Number:
WIPO Patent Application WO/2021/228216
Kind Code:
A1
Abstract:
The present invention relates to a compound of formula (I), and a stereisomer, a tautomer, a stable isotopic variant, a pharmaceutically acceptable salt or a solvate thereof, a pharmaceutical composition comprising the compound, a method for treating or preventing RORγt-related diseases by using the compound, and use of the compound in the preparation of drugs for treating or preventing the RORγt-related diseases.
Inventors:
CHENG YAOBANG (CN)
HUANG YAFEI (CN)
ZHOU JUAN (CN)
DONG ZHIQIANG (CN)
HUANG YAFEI (CN)
ZHOU JUAN (CN)
DONG ZHIQIANG (CN)
Application Number:
PCT/CN2021/093788
Publication Date:
November 18, 2021
Filing Date:
May 14, 2021
Export Citation:
Assignee:
SHANGHAI LITEDD CO LTD (CN)
International Classes:
C07D209/44; A61K31/4035; A61P1/04; A61P11/06; A61P17/06; A61P37/00; C07D217/24; C07D221/02
Foreign References:
| CN109071516A | 2018-12-21 | |||
| CN109879784A | 2019-06-14 | |||
| CN105272904A | 2016-01-27 | |||
| US20190192454A1 | 2019-06-27 |
Attorney, Agent or Firm:
ZHONGZI LAW OFFICE (CN)
Download PDF:
Previous Patent: BIARYL COMPOUND CAPABLE OF SERVING AS RORγ REGULATOR
Next Patent: ANILINE COMPOUND USED AS RORγ REGULATOR
Next Patent: ANILINE COMPOUND USED AS RORγ REGULATOR